Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau) ; volume:7 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-12 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (4.3.2019), 1-12, 12.2019
- Urheber
-
Gibbons, Garrett S.
Kim, Soo-Jung
Robinson, John L.
Changolkar, Lakshmi
Irwin, David J.
Shaw, Leslie M.
Lee, Virginia M.-Y
Trojanowski, John Q.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-019-0687-5
- URN
-
urn:nbn:de:101:1-2019033003292707313919
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gibbons, Garrett S.
- Kim, Soo-Jung
- Robinson, John L.
- Changolkar, Lakshmi
- Irwin, David J.
- Shaw, Leslie M.
- Lee, Virginia M.-Y
- Trojanowski, John Q.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau-Tau
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau
Tau
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau-Tau
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau
Tau
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau-Tau
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Propagation of Tau pathology in Alzheimer disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau